Novel skin-whitening agent |
| OF THE INVENTION The active ingredient in the skin-whitening agent of the present invention is the ... |
|
Skin whitener composition containing mercaptodextran |
| OF THE INVENTION In accordance with the present invention, a skin whitener composition is provided ... |
|
Composition for external application containing a .beta.-1,6-branched-.beta.-1,3-glucan |
| OF THE INVENTION Schizophyllum commune Fr. is woody rotting fungi belonging to Agaricales T... |
|
Method of hydrolyzing defatted jojoba meal with protease enzymes |
| The present invention is directed to a new form of jojoba protein, namely hydrolyzed jojoba protein ... |
|
Use of amidoamines to treat or prevent acanthamoeba and fungal infections |
| What is claimed is: 1. A method of treating infections attributable to Acanthamoeba, fungi or a ... |
|
1-(5-Trifluoromethyl-1, 3,4-thiadiazol-2-yl)-3-methyl-5-acetyloxy-1,3-imidazolidin-2-one |
| I claim: 1. The compound 1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)-3-methyl-5-acetyloxy-1,3-imida ... |
|
Confectioneries containing stabilized highly odorous flavor component delivery systems |
| AND PREFERRED EMBODIMENT It is known that food stimulates the sense of smell, taste and touch. The ... |
|
|
Method and composition for neutralizing house dust mite feces
| Details |
Inventors: Tyrrell, David J.; Krzysik, Duane G.;
Assignee: Kimberly-Clark Worldwide, Inc. (Neenah, WI)
Primary Examiner: Tate; Christopher R.
Assistant Examiner:
Attorney, Agent or Firm: Senniger Powers
Methods for neutralizing dust mite feces are disclosed. In one embodiment, a botanical extract having a BAPNA-Trypsin Inhibition (IC50×10-3 (%, v/v or w/v) of from about 0.01 to about 500 and a sufficient solubility in water is introduced into water to form an aqueous botanical extract solution. The aqueous botanical extract solution is atomized into an area being treated such that the botanical extract contacts and neutralizes the dust mite feces located in the area. Particularly preferred botanical extracts for use in the botanical extract aqueous solutions of the present invention include Green Tea Extra and Grape Seed Extract. |
|
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS In accordance with the present invention, it has been discovered that certain botanical extracts, whether in powder form or in liquid form, can be effectively utilized to reduce the allergenicity of allergens including dust mite feces. Surprisingly, substantially water soluble botanical extracts having a BAPNA-Trypsin Inhibition (IC50×10-3 (%, v/v or w/v)) of from about 0. 01 to about 500 as described herein can be introduced into water to form an aqueous botanical extract solution which can be utilized in atomized form to treat large areas quickly and easily to neutralize dust mite feces allergens. In preferred embodiments, the botanical extracts used to form the botanical extract solution have a solubility in water of at least about 0. 5% by weight, and more preferably at least about 1% by weight to ensure sufficient solubility of the botanical extract into the aqueous solution. Further, it is preferred that the median drop size of the atomized aqueous botanical extract solution be less than about 1000 micrometers to ensure effective coverage. Dust mites and feces from dust mites are present throughout many areas of homes as discussed above. Dust mite feces has been repeatedly shown to contain high levels of serine proteases, which are known to cause allergic responses in some humans when inhaled into the nose, throat, and lungs. Through vigorous investigation and experimentation, the inventors discovered that numerous botanical extracts have strong protease inhibitory activity and have high solubility in water. This combination of protease inhibitory activity and solubility in water allows a concentrated aqueous botanical extract solution to be prepared in accordance with the present invention that can be contacted with the feces of dust mites resulting in the neutralization of the feces such that the dust mite feces become substantially non-allergenic. One important aspect of the present invention is that the botanical extracts act to neutralize the allergenic feces of the dust mite, and do not simply kill some dust mites while leaving the feces to continue to act as an allergen if inhaled
|
| Related patents |
|
|
Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
What is claimed is: 1. A method for eliciting an enhanced analgesic and anti-inflammatory response in a mammalian organism in need of such treatment, comprising ...
|
|
|
Metal-containing compositions, preparations and uses
The invention claimed is: 1. A metal-containing composition consisting essentially of: (i) at least one water soluble metal compound which forms metal ions when ...
|
|
|
Antioxidant and/or antielastase composition based on lupine oil
What is claimed is: 1. A composition comprising lupine oil or one or more of its fractions for use as an antioxidant and/or antielastase. 2. The composition of claim 1, ...
|
|
|
Treatment for dry eye syndrome
OF THE PREFERRED EMBODIMENTS The present invention is an improved formulation for the treatment of the underlying inflammatory processes that cause dry eye syndrome. T...
|
|
|
Repellent aminoalkyldithiocarbamic acids
What is claimed is: 1. A method of repelling rodents or ruminants comprising applying to a rodent or ruminant habitat a repellent amount of a compound of the formula ##EQ...
|
|
|
Sustained release animal repellents
OF THE INVENTION Controlled release formulations in polymeric vehicles have been used for delivery of pesticides, insecticides, fertilizer, detergents, perfumes and in ...
|
|
|
Substance delivery device
In a first aspect, the pre nt invention provides a substance delivery device comprising a combustible paperboard strip and at least one of a substance toxic to insects ...
|
|
|
Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
OF THE PREFERRED EMBODIMENTS The compressed pharmaceutical dosage forms of the present invention rapidly disintegrates when contacted by water, saliva and aqueous ...
|
|
|
Pharmaceutical compositions containing at least one NSAID having increased bioavailability
OF THE INVENTION The incorporation of Piperine, its metabolites or structural analogues or isomers thereof with NSAIDs particularly Nimesulide or derivatives thereof ...
|
|
|
Controlled release compositions for macrolide antimicrobial agents
OF THE INVENTION In the context of the present invention a number of terms have been used. In order to provide a clear and consistent understanding of the specification,...
|
|
|